Mercury Laboratories Ltd

Mercury Laboratories Management Change

Mercury Laboratories has appointed Mr. Jaydeepsinh Raj as Manager-HR, effective September 03, 2026.

Mercury Laboratories Annual Report

Mercury Laboratories Ltd has submitted its 45th Annual Report and Notice of the 45th AGM for the financial year 2025-26.

Mercury Laboratories Annual General Meeting

Mercury Laboratories has issued the notice for its 45th Annual General Meeting, scheduled for September 28, 2026. The meeting will address dividend declaration and director re-appointments.

Mercury Laboratories Management Change

Mercury Laboratories appointed Sunil Sharma as Head of Injectable Production effective August 21, 2026. Simultaneously, Ms. Seema Salvi resigned from the same position to pursue other opportunities.

Mercury Laboratories Other Announcement

Mercury Laboratories informs shareholders regarding Tax Deduction at Source (TDS) requirements for the FY 2025-26 dividend. This communication outlines necessary compliance and record-updating procedures.

Mercury Laboratories Q1 FY27 Results: Net Profit ₹0.3 Cr, Down 70.0% YoY

Mercury Laboratories Ltd reported revenue from operations of ₹16 Cr (-11.6% YoY) and net profit of ₹0.3 Cr (-70.0% YoY) for Q1 FY27.

Key figure

Net profit ₹0.3 Cr · -70.0% YoY

Mercury Laboratories Board Meeting Date

Mercury Laboratories scheduled a board meeting for July 25, 2026. The board will consider and approve unaudited financial results for the June quarter.

Mercury Laboratories Credit Rating

CRISIL reaffirmed the credit rating of Mercury Laboratories' ₹3 Crore fixed deposits at 'CRISIL BB+/Stable'. This indicates a moderate risk of default.

Value

₹3.00 Cr

Mercury Laboratories Management Change

Mercury Laboratories Limited appointed Mr. Binaya Kumar Panigrahi as Plant Head for its Jarod Unit. He brings over 24 years of expertise in pharmaceutical tablet manufacturing.

Mercury Laboratories Results Correction

Mercury Laboratories resubmitted its audited FY2026 financial results to correct typographical errors in the balance sheet and cash flow statement. No other material changes were reported.

Mercury Laboratories Management Change

Mercury Laboratories appointed M/s K R & Associates as Internal Auditor and M/s V. M. Patel & Associates as Cost Auditor for FY 2026-27. Both are re-appointments.

Execution

FY 2026-27

Mercury Laboratories Dividend

Mercury Laboratories declared a final dividend of ₹3.5 per equity share for FY26. The record date is September 21, 2026, pending shareholder approval at the AGM.

Mercury Laboratories Q4 FY26 Results: Net Profit ₹1.2 Cr, Up 9.1% YoY

Mercury Laboratories Ltd reported revenue from operations of ₹20.4 Cr (-1.4% YoY) and net profit of ₹1.2 Cr (+9.1% YoY) for Q4 FY26.

Key figure

Net profit ₹1.2 Cr · +9.1% YoY

Mercury Laboratories Financial Results

Mercury Laboratories approved its FY26 audited results reporting a total income of ₹77.89 Crore. The board recommended a 35% dividend alongside the annual performance update.

Value

₹77.89 Cr

Mercury Laboratories Other Announcement

Mercury Laboratories filed its Annual Secretarial Compliance Report for the financial year 2025-26. The report by Dholakia & Associates confirms no material non-compliance or penalties.

Mercury Laboratories Board Meeting Date

Mercury Laboratories Limited scheduled a board meeting for May 29, 2026. Directors will consider audited financial results and potential dividend recommendations for the fiscal year.

Mercury Laboratories Other Announcement

Mercury Laboratories Ltd has issued an intimation regarding the mandatory transfer of equity shares to the IEPF Authority. This applies to shareholders who have not claimed dividends for seven consecutive years starting from FY 2018-19. Shareholders must claim their unclaimed dividends by November 02, 2026, to avoid the share transfer.

Mercury Laboratories Debt & Borrowing

Mercury Laboratories Ltd submitted its annual disclosure for FY 2025-26 under the SEBI Large Corporate framework. The company confirmed it was not identified as a Large Corporate (LC) for the period, resulting in nil mandatory borrowing requirements through debt securities and no applicable penalties.

Mercury Laboratories Management Change

Mercury Laboratories Limited announced the resignation of Mr. Sandip Patel, Plant Head-Jarod and Senior Management Personnel, effective April 28, 2026. Mr. Patel resigned to pursue better opportunities and career advancement. The company confirmed there are no other material reasons for his departure.

Mercury Laboratories Debt & Borrowing: ₹7.31 Cr

Mercury Laboratories Ltd disclosed an outstanding borrowing of ₹7.31 Crore as of March 31, 2026. Under SEBI's Large Corporate framework, the company confirmed its status and reported a BB+/Stable credit rating from CRISIL Limited.

Value

₹7.31 Cr

Mercury Laboratories Other Announcement

Mercury Laboratories Ltd submitted its quarterly confirmation certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the period ended March 31, 2026. The registrar, MUFG Intime India, confirmed that security certificates received for dematerialisation were processed and listed on the relevant exchanges within prescribed timelines.